radicamine B: structure in first source
ID Source | ID |
---|---|
PubMed CID | 15953621 |
CHEMBL ID | 466791 |
SCHEMBL ID | 13848027 |
MeSH ID | M0419017 |
Synonym |
---|
(2r,3r,4r,5r)-2-(hydroxymethyl)-5-(4-hydroxyphenyl)pyrrolidine-3,4-diol |
7E79EEAE-B5A3-481B-A039-B6DA9C270415 |
CHEMBL466791 |
radicamine b |
SCHEMBL13848027 |
431981-75-8 |
XR175854 |
3,4-pyrrolidinediol,2-(hydroxymethyl)-5-(4-hydroxyphenyl)-,(2s,3s,4s,5s)-(9ci) |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID412140 | Inhibition of Helix pomatia beta-mannosidase | 2008 | Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24 | Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library. |
AID412139 | Inhibition of yeast alpha-glucosidase | 2008 | Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24 | Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library. |
AID412141 | Inhibition of almond beta-glucosidase | 2008 | Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24 | Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library. |
AID412138 | Inhibition of Bacillus stearothermophilus alpha-glucosidase | 2008 | Bioorganic & medicinal chemistry, Dec-15, Volume: 16, Issue:24 | Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.43) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |